1-10 of 10
primary central nervous system lymphoma
Close
Sort by
Journal Articles

Improving the antitumor activity of R-CHOP with NGR-hTNF in primary CNS lymphoma: final results of a phase 2 trial

Clinical Trials & Observations
Andrés J. M. Ferreri, Teresa Calimeri, Maurilio Ponzoni, Flavio Curnis, Gian Marco Conte, Eloise Scarano, Eltjona Rrapaj, Daniela De Lorenzo, Dario Cattaneo, Federico Fallanca, Alessandro Nonis, Marco Foppoli, Paolo Lopedote, Giovanni Citterio, Letterio S. Politi, Marianna Sassone, Piera Angelillo, Elena Guggiari, Sara Steffanoni, Vittoria Tarantino, Fabio Ciceri, Claudio Bordignon, Nicoletta Anzalone, Angelo Corti
Journal: Blood Advances
Blood Adv (2020) 4 (15): 3648–3658.
https://doi.org/10.1182/bloodadvances.2020002270
Published: 2020
Includes: Multimedia, Supplemental data
Journal Articles

High-dose chemotherapy and autologous stem cell transplant in elderly patients with primary CNS lymphoma: a pilot study

Clinical Trials & Observations
Elisabeth Schorb, Benjamin Kasenda, Gabriele Ihorst, Florian Scherer, Julia Wendler, Lisa Isbell, Heidi Fricker, Juergen Finke, Gerald Illerhaus
Journal: Blood Advances
Blood Adv (2020) 4 (14): 3378–3381.
https://doi.org/10.1182/bloodadvances.2020002064
Published: 2020
Includes: Supplemental data
Journal Articles

Primary vitreoretinal lymphomas display a remarkably restricted immunoglobulin gene repertoire

Nabila Belhouachi, Aliki Xochelli, Myriam Boudjoghra, Claude Lesty, Nathalie Cassoux, Christine Fardeau, Thi Ha Chau Tran, Sylvain Choquet, Bishnu Sarker, Caroline Houillier, Agusti Alentorn, Phuc LeHoang, Carole Soussain, Valerie Touitou, Helene Merle-Beral, Khe Hoang-Xuan, Bahram Bodaghi, Kostas Stamatopoulos, Frederic Davi
Journal: Blood Advances
Blood Adv (2020) 4 (7): 1357–1366.
https://doi.org/10.1182/bloodadvances.2019000980
Published: 2020
Includes: Supplemental data
Journal Articles

Attarbaschi A, Abla O, Ronceray L, et al. Primary central nervous system lymphoma: initial features, outcome, and late effects in 75 children and adolescents. Blood Adv. 2019;3(24):4291-4297.

Journal: Blood Advances
Blood Adv (2020) 4 (6): 1012.
https://doi.org/10.1182/bloodadvances.2020001770
Published: 2020
Journal Articles

Primary central nervous system lymphoma: initial features, outcome, and late effects in 75 children and adolescents

Clinical Trials & Observations
Andishe Attarbaschi, Oussama Abla, Leila Ronceray, Shweta Bansil, Simon Bomken, Birgit Burkhardt, Francesco Ceppi, Alan K. S. Chiang, Hema Dave, Alina Fedorova, Michael Henry, Janez Jazbec, Edita Kabickova, Rishi S. Kotecha, Jelena Lazic, Jan Loeffen, Natalia Miakova, Tomoo Osumi, Marta Pillon, Apostolos Pourtsidis, Charlotte Rigaud, Gevorg Tamamyan, Sneha Tandon, Anne Uyttebroeck, Jamie Verdu-Amoros, Wilhelm Woessmann, Grazyna Wrobel, Lisa Giulino-Roth
Journal: Blood Advances
Blood Adv (2019) 3 (24): 4291–4297.
https://doi.org/10.1182/bloodadvances.2019001062
Published: 2019
Includes: Supplemental data
Journal Articles

Molecular features of a large cohort of primary central nervous system lymphoma using tissue microarray

Clinical Trials & Observations
Diego Villa, King L. Tan, Christian Steidl, Susana Ben-Neriah, Muntadhar Al Moosawi, Tamara N. Shenkier, Joseph M. Connors, Laurie H. Sehn, Kerry J. Savage, David W. Scott, Randy D. Gascoyne, Graham W. Slack
Journal: Blood Advances
Blood Adv (2019) 3 (23): 3953–3961.
https://doi.org/10.1182/bloodadvances.2019000989
Published: 2019
Includes: Supplemental data
Journal Articles

MYD88 L265P mutation and CDKN2A loss are early mutational events in primary central nervous system diffuse large B-cell lymphomas

Naema Nayyar, Michael D. White, Corey M. Gill, Matthew Lastrapes, Mia Bertalan, Alexander Kaplan, Megan R. D’Andrea, Ivanna Bihun, Andrew Kaneb, Jorg Dietrich, Judith A. Ferry, Maria Martinez-Lage, Anita Giobbie-Hurder, Darrell R. Borger, Fausto J. Rodriguez, Matthew P. Frosch, Emily Batchelor, Kaitlin Hoang, Benjamin Kuter, Sarah Fortin, Matthias Holdhoff, Daniel P. Cahill, Scott Carter, Priscilla K. Brastianos, Tracy T. Batchelor
Journal: Blood Advances
Blood Adv (2019) 3 (3): 375–383.
https://doi.org/10.1182/bloodadvances.2018027672
Published: 2019
Journal Articles

Phase 1 investigation of lenalidomide/rituximab plus outcomes of lenalidomide maintenance in relapsed CNS lymphoma

Clinical Trials & Observations
James L. Rubenstein, Huimin Geng, Eleanor J. Fraser, Paul Formaker, Lingjing Chen, Jigyasa Sharma, Phoebe Killea, Kaylee Choi, Jenny Ventura, John Kurhanewicz, Clifford Lowell, Jimmy Hwang, Patrick Treseler, Penny K. Sneed, Jing Li, Xiaomin Wang, Nianhang Chen, Jon Gangoiti, Pamela N. Munster, Bertil Damato
Journal: Blood Advances
Blood Adv (2018) 2 (13): 1595–1607.
https://doi.org/10.1182/bloodadvances.2017014845
Published: 2018
Includes: Supplemental data
Journal Articles

Checkpoint blockade in Hodgkin and non-Hodgkin lymphoma

Reid W. Merryman, Philippe Armand, Kyle T. Wright, Scott J. Rodig
Journal: Blood Advances
Blood Adv (2017) 1 (26): 2643–2654.
https://doi.org/10.1182/bloodadvances.2017012534
Published: 2017
Journal Articles

Therapy and outcomes of primary central nervous system lymphoma in the United States: analysis of the National Cancer Database

Clinical Trials & Observations
Jaleh Fallah, Lindor Qunaj, Adam J. Olszewski
Journal: Blood Advances
Blood Adv (2016) 1 (2): 112–121.
https://doi.org/10.1182/bloodadvances.2016000927
Published: 2016
Includes: Supplemental data